Effect of Playing an Audio Clip for Pain and Anxiety Control in Patients While Dressing Burn Wounds

July 10, 2024 updated by: Resmi Lekhadevi, Hamad Medical Corporation

Effect of Playing an Audio Clip for Pain and Anxiety Control for Burn Patients While Dressing Burn Wounds: Randomized Controlled Trial

The aim of this clinical trial is to assess the effect of playing patient preferred audio clip for controlling the pain and anxiety in patients while dressing burn wounds. The age group to be selected for this explicit examination is 18 years and above. The researcher will assess the pain and anxiety levels in both experimental and control groups having sample size of 50 each using standardized tools. The patient in intervention group will be offered selected audio clips to choose from. The patient preferred audio clips will be played for 10 days while the control group will be provided with treatment as usual. After collecting the data from both groups, it will be compared to analyze the effectiveness of listening to the audio clips chosen by the patient.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Burn related pain and anxiety is an important health problem. Surgical procedures and physical rehabilitation is commonly associated with pain and anxiety among burn injuries. Burn pain initially associated with size and degree of burn followed by post rehabilitation procedures and infections. Pain during burn incident and expectation of pain in treatment procedures create severe anxiety in most of the patients. In this investigation researcher is going to use listening to an audio clip (piece of self-selected music, sound from nature, or religious recitations) as a non-pharmacological intervention. Audio pieces are used for clinical purposes as complementary and alternative medicine. Although it is not practiced extensively due to the lack of evidence-based results in this particular area of research. This is an open label Randomized controlled trial aimed to assess the effectiveness of listening to an audio clip as an adjunct to TAU among hospitalized burns patient.

This study is open label, prospective, parallel group, randomized control design. The trial compares thosepatients with intervention group and control group with treatment as usual. Based on the inclusion criteria those patients with 10-30% of burns and need to stay in hospital for 10 days and withpain score of >=4 will be included in the study. The samples will be divided into two groups by randomly assigning the patients to each group. The analysis will be conducted to assess the effectiveness of listening to an audio clip for controlling pain and anxiety. No blinding or masking will be performed in this study.The patients in the intervention group will be introduced to the music player before and the procedure. After the preparation of the intervention subsequently on the same day or during the next day's prior to dressing NRS and BAI will be administered to evaluate the patient's pain and anxiety levels. After completion of intervention pain, anxiety and hemodynamic parameters will be collected. Treatment as usual will be provided for all control group patients as per Unit Protocol. The primary outcome was reduced pain and anxiety levels during the dressing changes as evidenced by reducing 15-20% in experimental group as compared to control group with treatment as usual.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Doha, Qatar, 82228
        • Hamad Medical Corporation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All adult patients aged 18 years and above.
  • Fit the diagnostic standard of severe burn injury as per the clinical guidelines with burns up to10%
  • 30% the total body surface area. (TBSA).
  • Hospitalized burn patients with an expected stay in hospital for 10 days at the time of signing the informed consent.
  • Patient needs to be literate to understand the instruction and the audio clip and provide response for the questionnaire.
  • Pain score before intervention >=4 NRS (moderate pain

Exclusion Criteria:

  • Burn patients who are critically ill with ventilator support,
  • Burn patient with respiratory problem or hearing impairment,
  • Burn patients with cognitive impairments.
  • Burn patient with diabetic neuropathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
The experimental group consists of 50 Participants as per the inclusion criteria. The Audio clips will be administered to the experimental group.
Selected Audio clips will be introduced to the study subjects during the Burns Dressing Changes. The Audio Clips will be selected as per subjects preference.
No Intervention: Control Group
The control group will not receive the intervention but will receive treatment as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in pain intensity
Time Frame: Throughout study completion up to 10 days after randomization.
Measures the changes in pain intensity with a Numerical Rating Scale from 0-10 with higher score indicates higher levels of pain and lower scores indicates less pain 15-20% in experimental group as compared to control group with treatment as usual.
Throughout study completion up to 10 days after randomization.
changes in anxiety level
Time Frame: Throughout study completion up to10 days after randomization.
Measures the changes in anxiety with Beck Anxiety Inventory scale from 0-63 maximum scores. Higher scores indicate higher levels of anxiety and lower scores indicates lower levels of anxiety.
Throughout study completion up to10 days after randomization.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in Heart rate
Time Frame: Throughout study completion up to10 days after randamization .
Measures changes in heart rate via hospital monitors , these changes are in beats per minute(bpm) and will be obtained prior to pre-intervention phase and immediately after post intervention phase.
Throughout study completion up to10 days after randamization .
changes in Respiratory rate
Time Frame: Throughout study completion up to10 days after randomization.
Measures changes in heart rate via hospital monitors ,these changes are in breaths per minute(bpm) and will be obtained prior to pre-intervention phase and immediately after post intervention phase.
Throughout study completion up to10 days after randomization.
Changes in Blood Pressure
Time Frame: Throughout study completion up to 10 days after randomization.
Measures changes in blood pressure via hospital monitors ,these changes are in millimeters of mercury (mm hg) and will be obtained prior to pre-intervention phase and immediately after post intervention phase.
Throughout study completion up to 10 days after randomization.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication intake
Time Frame: Throughout study completion up to 10 days after randomization.
Rescue doses asked by the patient
Throughout study completion up to 10 days after randomization.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

March 30, 2024

Study Completion (Actual)

March 30, 2024

Study Registration Dates

First Submitted

August 18, 2022

First Submitted That Met QC Criteria

August 24, 2022

First Posted (Actual)

August 25, 2022

Study Record Updates

Last Update Posted (Actual)

July 11, 2024

Last Update Submitted That Met QC Criteria

July 10, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MRC-01-22-239

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The Study data of Participants will not be shared outside Hamad Medical Corporation. The Data Will be managed according to the Norms of HMC- Medical Research Centre.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Audio Clip

Subscribe